Guidance on efficacy requirements for biocides: Hard-surface disinfection and sanitization
On this page
- Types of claims
- General claims
- Hard-surface disinfectant claims
- Non-food contact and food contact sanitizers on hard surfaces
- Residual disinfection and sanitization
Types of claims
In general, there are 2 different types of biocidal claims:
- specific claims
- direct claims
- indirect claims
- general claims
Direct claims show a causal relationship. These claims require efficacy information that demonstrates your biocide is effective against specific microorganisms. An example of a direct claim would be "This biocide kills SARS-CoV-2 (the virus that causes COVID-19)".
Indirect claims show a relationship and are only accepted during a declared pandemic by the World Health Organization (WHO). These claims allow you to provide Health Canada with efficacy testing using another microorganism that's similar or harder to kill than the proposed microorganism. An example of an indirect claim would be "This biocide kills rhinovirus type 16 and is likely to kill SARS-CoV-2 (the virus that causes COVID-19)".
If your biocide qualifies for both a direct and an indirect claim, you should only include the direct claim on the label.
Learn more about claims against emerging pathogens.
General claims
Before proposing a general claim for your biocide, you should first demonstrate if your biocide is a general (broad-spectrum) biocide or a hospital or health care disinfectant. This applies to claims to destroy (kill), inactivate or reduce or control the number of:
- germs
- viruses
- mycobacteria
- specific bacterial spores
- fungi, mould and mildew
- other non-spore forming bacteria
- such as Escherichia coli
To propose a specific non-food contact surface sanitization claim, you should demonstrate that your biocide is a general non-food contact surface sanitizer. The same applies for specific food contact surface sanitization claims.
Studies to support your biocide application may be electronically signed by laboratories. This includes efficacy reports containing good laboratory practice (GLP) statements.
Hard-surface disinfectant claims
Disinfectants can destroy or irreversibly inactivate pathogenic (disease-causing) and potentially pathogenic (opportunistic) microorganisms, but not necessarily bacterial spores, on hard surfaces. This is because of the antimicrobial action of the active ingredients.
Hard-surface disinfectants against bacteria should show they're effective 10 minutes after application or sooner.
Limited, general (broad-spectrum) and hospital or health care disinfection
For limited, general (broad-spectrum) and hospital or health care disinfectant claims, we require:
- 3 samples of the biocide representing 3 separate batches per representative test organism for the bactericide
- 60 inoculated carriers per batch per bacterium
The testing requirements for limited, general (broad-spectrum) and hospital or health care disinfectants are listed in Table 3.
Use the following methods for testing these core bacteria for disinfection claims:
- Staphylococcus aureus: AOAC 955.15 method
- Pseudomonas aeruginosa: AOAC 964.02 method
- Salmonella enterica: AOAC 955.14 method
You should conduct 3 independent tests on 3 different test days for Pseudomonas aeruginosa and Staphylococcus aureus. You should test for Salmonella enterica on different days.
Claims against bacteria allow you to label your biocide as a "bactericide" and a "bactericidal". You must provide efficacy data to show different levels of efficacy for your biocide.
Claim | Physical form, method of application | Recommended test methods |
Test organisms | Number of batches per organism, carriers per batch | Inoculum or carrier count | Performance criteria for efficacy | |
---|---|---|---|---|---|---|---|
Core bacteria test requirements | |||||||
Limited disinfectant (effective against Gram-positive or Gram-negative, but not both) |
Liquids (cloth, mop, immersion applications)Footnote 1 Water-soluble |
AOAC use-dilution method 955.14, 955.15 |
Salmonella enterica (formerly Salmonella choleraesuis) (ATCC 10708) or Staphylococcus aureus (ATCC 6538) |
3 LCL batches 60 carriers per batch |
As prescribed in current test methods Unless otherwise prescribed AOAC use-dilution methods: S. enterica: 1.0 x 105 to 1.0 x 106 CFU per carrier (minimum mean 5 log10 density) S. aureus and P. aeruginosa, each batch to be tested on a different day: 1.0 x 106 to 1.0 x 107 CFU per carrier (minimum mean 6 log10 density) AOAC 961.02 and towelette methods: S. enterica: 1.0 x 104 to 3.2 x 105 CFU per carrier (minimum mean 4 log10 density) S. aureus and P. aeruginosa: 1.0 x 105 to 3.2 x 106 CFU per carrier (minimum mean 5 log10 density) |
As prescribed in current test methods, per batch at proposed contact time Unless otherwise prescribed AOAC 955.14 testing against S. enterica: 59/60 carriers negative for growth AOAC 955.15 AOAC 964.02 testing against P. aeruginosa: 54/60 carriers negative for growth per batch AOAC 961.02 and towelette methods: 59/60 carriers negative for growth |
|
SprayFootnote 1 |
AOAC 961.02 |
||||||
Single-use towelettes |
Modified AOAC 961.02 ASTM E2362 |
||||||
General (broad-spectrum) disinfectantFootnote 2 (effective against Gram-positive and Gram-negative) |
Liquids |
AOAC use- dilution method 955.14 |
Staphylococcus aureus and Salmonella enterica (formerly Salmonella choleraesuis) (ATCC 10708) or Pseudomonas aeruginosa (ATCC 15442) |
||||
Spray |
AOAC 961.02 |
||||||
Single-use towelettes |
Modified AOAC 961.02 ASTM E2362 |
||||||
Hospital and health care disinfectantFootnote 2 (effective against Gram-positive and Gram-negative) |
Liquids Water-soluble powders |
AOAC use- dilution method 964.02, 955.15 |
Pseudomonas aeruginosa (ATCC 15442) and Staphylococcus aureus (ATCC 6538) |
||||
Spray |
AOAC 961.02 |
||||||
Single-use towelettes |
Modified AOAC 961.02 ASTM E2362 |
||||||
Additional bacteria test requirements | |||||||
Claim against additional bacterium (non-spore forming) |
Liquids Water-soluble powders |
AOAC use-dilution method |
Specific bacterium claimed on the label in addition to the general (broad-spectrum) or hospital or health care disinfectant claim |
2 NCL batches (separately compounded per representative test organism) 10 carriers per batch |
As prescribed in current test methods Unless otherwise prescribed: 1.0 x 104 to 1.0 x 105 CFU per carrier |
Unless otherwise prescribed: 10/10 carriers negative for growth per batch at proposed contact time |
|
Spray |
AOAC 961.02 |
||||||
Single-use towelettes |
Modified AOAC 961.02 ASTM E2362 |
||||||
Confirmatory efficacy data requirements for bacteria disinfection | |||||||
General (broad-spectrum) disinfectant |
Same as core bacteria requirements |
2 LCL batches 10 carriers per batch |
Same as core bacteria requirements |
||||
Hospital or health care disinfectant |
Same as core bacteria requirements |
2 LCL batches 10 carriers per batch |
Same as core bacteria requirements |
||||
Abbreviation:
|
Mycobacteria disinfection
You will need efficacy data against a representative Mycobacterium species to claim your biocide as a:
- mycobactericide
- mycobactericidal
A representative species could be Mycobacterium bovis BCG (ATCC 35473) or Mycobacterium terrae (ATCC 15755).
To make specific claims against certain mycobacteria, you must provide supporting efficacy data.
Only include specific claims (for example, effective against or kills Mycobacterium fortuitum) on your label if you:
- do not have efficacy data to support your biocide as a "mycobactericide" or "mycobactericidal" biocide
- have efficacy data to support the specific claim
Note: Mycobacterium terrae (ATCC 15755) has only been validated with the:
- ASTM quantitative carrier methods (ASTM E2111 and E2197)
- OECD quantitative method
If you have quaternary ammonium compounds as the sole active ingredient in your biocide, you should perform verification testing to confirm the mycobactericidal label claim. To do so, you must test 1 of the original biocide lots using the same test procedures and under the same conditions. Testing must be done in either:
- a different laboratory than the original one
- the same laboratory using different laboratory personnel
- for example, different study director, technical staff and quality assurance (QA) auditor
Claim | Physical form, method of application | Recommended test methods | Test organisms | Number of batches per organism, carriers per batch | Inoculum or carrier count | Performance criteria for efficacy | |
---|---|---|---|---|---|---|---|
Core mycobacteria test requirements | |||||||
Mycobactericide and tuberculocide | Liquids Water-soluble powders |
AOAC 965.12 US EPA QTBFootnote 1 |
Choosing the appropriate Mycobacterium species depends on the test method: Mycobacterium bovis (BCG) (ATCC 35743) or Mycobacterium terraeFootnote 2 (ATCC 15755) |
2 LCL batches 10 carriers per batch For the QTB method: |
As prescribed in current test methods Unless otherwise prescribed: QTB method: 1 x 107 to 1 x 108 CFU per mL Carrier test method: 1 x 104 to 1.0 x 106 CFU per carrier |
As prescribed in current test methods and at proposed contact time Unless otherwise prescribed: Carrier test method: 10/10 carriers negative for growth per batch at specified contact time, no growth in inoculated subculture media QTB method: each of 4 replicates should demonstrate less than or equal to 1.0 x 104 CFU (less than or equal to 4.0 log10 kill, 99.99% reduction) |
|
Spray | AOAC 961.0 modified for mycobacteria | ||||||
Single-use towelettes | Modified AOAC 961.02 ASTM E2362 |
||||||
Additional mycobacteria test requirements | |||||||
Claim against specific mycobacteriaFootnote 1 | Liquids Water-soluble powders |
AOAC 965.12 US EPA QTB1 |
Any specific mycobacteria claimed on the label | 2 NCL batches, 10 carriers per batch QTB method: |
As prescribed in current test methods Unless otherwise prescribed: QTB method: 1 x 107 to 1 x 108 CFU per mL Carrier test method: 1 x 104 to 1.0 x 106 CFU per carrier |
As prescribed in current test methods and at proposed contact time Unless otherwise prescribed: Carrier test method: 10/10 carriers negative for growth per batch at specified contact time, no growth in inoculated subculture media QTB method: Each of 4 replicates should demonstrate less than or equal to 1.0 x 104 CFU (less than or equal to 4.0 log10 kill, 99.99% reduction) |
|
Spray | AOAC 961.02 modified for mycobacteria | ||||||
Single-use towelettes | Modified AOAC 961.02 ASTM E2362 | ||||||
Confirmatory efficacy data requirements for mycobacteria disinfection | |||||||
Mycobactericide and tuberculocide | Refer to core mycobacteria requirements | 1 LCL batch 10 carriers per batch QTB method: |
Refer to core mycobacteria requirements | ||||
Abbreviation:
Footnotes
|
Fungi
To make claims against fungi for your biocide, you must conduct fungicidal testing using fungal conidia (spores). You can only label your biocide as a fungicide or fungicidal if your efficacy testing is against Trichophyton interdigitale (formerly Trichophyton mentagrophytes) (ATCC 9533).
If you want to make specific claims against certain fungi, you must provide supporting efficacy data. If you don't have efficacy data to support a general fungicide claim, you may indicate a specific fungus claim on your label.
Claim | Physical form, method of application | Recommended test methods | Test organisms | Number of batches per organism, carriers per batch | Inoculum or carrier count | Performance criteria for efficacy |
---|---|---|---|---|---|---|
Core fungi test requirements | ||||||
Fungicide | Liquids Water-soluble powders |
AOAC 955.17/ AOAC use-dilution methods (UDM) modified for fungi |
Trichophyton interdigitale (formerly Trichophyton mentagrophytes) (ATCC 9533) | 2 LCL batches, 10 carriers (for carrier test methods) AOAC 955.17 suspension method: 2 LCL batches, 0 carrier |
As prescribed in current test methods Unless otherwise prescribed: AOAC 955.17 suspension method: 5 x 106 conidia to 5 x 107 conidia per mL Carrier test method: 1 x 104 conidia to 1 x 105 conidia per carrier |
As prescribed in current test methods and at proposed contact time AOAC 955.17 suspension method: test conducted at 10-min exposure time or less All fungal spores killed at 10 min or less to support a 10-min contact time Carrier test method: 10/10 carriers negative for growth per batch at prescribed contact time |
Spray | AOAC 961.02 modified for fungi | |||||
Single-use towelettesFootnote 1 | Modified AOAC 961.02 ASTM E2362 | |||||
Claim against specific fungus (for example, C. auris)Footnote 2 | Liquids Water-soluble powders |
AOAC 955.17 AOAC use-dilution methods (UDM) modified for fungi |
Any specific fungus claimed on the label | If the biocide also showed efficacy as a fungicide: 2 NCLFootnote 3 batches, 10 carriers (for carrier test method) AOAC 955.17 suspension method: 2 NCL batches, 0 carrier If the biocide has not been tested as a fungicide: 2 LCLFootnote 2 batches, 10 carriers (for carrier test method) AOAC 955.17 suspension method: 2 LCL batches, 0 carrier |
As prescribed in current test methods Unless otherwise prescribed: AOAC 955.17 suspension method: 5 x 106 conidia to 5 x 107 conidia per mL Carrier test method: 1 x 104 conidia to 1 x 105 conidia per carrier |
As prescribed in current test methods and at proposed contact time AOAC 955.17 All fungal spores killed at 10 min or less to support a 10-min contact time Carrier test method: 10/10 carriers negative for growth per batch at prescribed contact time |
Spray | AOAC 961.02 modified for fungi | |||||
Single-use towelettes | Modified AOAC 961.02 ASTM E2362 |
|||||
Confirmatory efficacy data requirements for fungi disinfection | ||||||
Fungicide | Refer to core microorganism requirements | 2 LCL batches, 10 carriers (for carrier test method) AOAC 955.17 suspension method: 2 LCL batches, 1 carrier |
Refer to core microorganism requirements | |||
Abbreviation:
Footnotes
|
Virus disinfection
To have claims against viruses on your biocide label, you must show that your biocide is either a:
- virucide
- may include claims against specific viruses
- broad-spectrum virucide
For broad-spectrum virucide claims, you must:
- test using 2 samples of the biocide representing 2 separately compounded batches per virus
- test on 1 inoculated carrier or surface per batch per virus (except when using surrogate viruses)
- test in quadruplicates at each dilution level
For all virus claims, you should use the ASTM E1053 test method with:
- an assay to detect the presence of remaining viable virus after treating the virus with the biocide, using the appropriate virological technique, such as:
- cytopathic effect
- fluorescent antibody
- plaque count
- 4 determinants per dilution in the assay system in the:
- virus recovery (control carrier counts)
- cytotoxicity control
- neutralization controls
- treated carriers (test for disinfectant activity)
Note: For a modified ASTM E1053 method, use 1 towelette to wipe 1 test carrier (the carrier is large and the folded towelette is small). We recommend that you either:
- treat carriers in 2 parallel sections using the same towelette or
- use the wiping technique in ASTM E2896 for viral testing
Use an appropriate statistical method to calculate the 50% infectious dose (ID50) for each assay. Examples of appropriate methods include:
- Reed and Munch
- Most Probable Number
- Spearman-Karber
The hardest-to-kill virus on the label should be tested at or below the LCL. This is any small and non-enveloped virus that's indicated on the label, if present (for example, feline calicivirus, rhinovirus).
All easier-to-kill viruses can be tested at or below the nominal concentration (NCL). If there are no small non-enveloped viruses on the label, then it's 1 of the large non-enveloped viruses on the label (for example, adenovirus type 5, rotavirus).
If the biocide indicates claims only against enveloped viruses, then testing should be conducted at LCL against any 1 of the enveloped viruses (for example, SARS-CoV-2).
Claim | Physical form, method of application | Recommended test | Test organism | Number of batches per organism, carriers and surfaces per batch | Inoculum or carrier count | Performance criteria for efficacy |
---|---|---|---|---|---|---|
Core virus test requirements | ||||||
Virucide |
Liquids Water-soluble powders |
ASTM E1053 |
Specific virus claimed on label except for surrogate viruses for efficacy claims against human hepatitis B virus (HBV), human hepatitis C virus (HCV) and norovirus |
2 LCL batches, 1 carrier per batch for hardest-to-kill virus on the labelFootnote 1 Easier-to-kill viruses can be tested using 2 NCL batches, 1 carrier per batch |
Unless otherwise prescribed: Minimum recoverable endpoint viral titer after drying between 104.80 (6.3 x 104) and 106.3 (1.9 x 106) per carrier |
As prescribed in current test methods and at proposed contact time Host cell line should exhibit cytopathic effects (CPE) in the presence of the selected virus Neutralization control should demonstrate complete neutralization of the biocide Unless otherwise prescribed: If cytotoxicity is present, a minimum 3 log10 reduction in viral titer beyond the cytotoxic level for all test carriers |
Spray |
ASTM E1053 |
|||||
Single-use towelettes |
Modified ASTM E1053 |
|||||
Broad-spectrum virucide |
Liquids Water-soluble powders |
ASTM E1053 |
Testing against any small non-enveloped virus from the following families:
|
2 LCL batches, 1 carrier per batchFootnote 2 |
||
Spray |
ASTM E1053 |
|||||
Single-use towelettes |
Modified ASTM E1053 |
|||||
Confirmatory efficacy data requirements for virus disinfection | ||||||
Virucide |
Refer to core microorganism requirements |
2 LCL batches, 1 carrier or batch for hardest-to-kill virus on the labelFootnote 1 |
Refer to core microorganism requirements |
|||
Broad-spectrum virucide |
2 LCL batches 1 carrier in quadruplicate per batchFootnote 2 |
|||||
|
Surrogate efficacy
You may use the following surrogate viruses to generate efficacy data for some virucide claims:
- duck hepatitis B virus (DHBV) for hepatitis B virus (HBV)
- bovine viral diarrhoea virus (BVDV) for hepatitis C virus (HCV)
- feline calicivirus for human norovirus
Note: Testing against 2 determinants per dilution in the assay system is acceptable for cytotoxicity and neutralization controls.
Claim | Physical form, method of application | Recommended test methods | Test organisms | Number of batches per organism, carriers and surfaces per batch | Inoculum or carrier count | Performance criteria for efficacy |
---|---|---|---|---|---|---|
Core surrogate virus test requirements | ||||||
Human hepatitis B virus (HBV) claim supported by surrogate efficacy |
Liquids Water-soluble powders |
Duck hepatitis B virus (DHBV) |
2 LCL batches 2 carriers in quadruplicate or batch |
Unless otherwise prescribed: Minimum recoverable endpoint viral titer after drying between 104.80 (6.3 x 104) and 106.3 (1.9 x 106) per carrier is required |
As prescribed in current test methods and at proposed contact time Host cell line should exhibit cytopathic effects (CPE) in the presence of the selected virus Neutralization control should demonstrate complete neutralization of the biocide Unless otherwise prescribed: If cytotoxicity is present, a minimum 3 log10 reduction in viral titer beyond the cytotoxic level for all test carriers |
|
Spray |
||||||
Single-use towelettes |
||||||
Human hepatitis C virus (HCV) claim supported by surrogate efficacy |
Liquids Water-soluble powders |
Bovine viral diarrhea virus (BVDV) |
||||
Spray |
||||||
Single-use towelettes |
||||||
Human norovirus claim supported by surrogate efficacy |
Liquids Water-soluble powders |
US EPA's Initial virucidal effectiveness test: Using feline calicivirus as surrogate for norovirus |
Feline calicivirus |
|||
Spray |
||||||
Single-use towelettes |
||||||
Confirmatory efficacy data requirements for viruses supported by surrogates | ||||||
Human norovirusFootnote 1 |
Refer to core requirements |
2 LCL batches, 2 carriers per batch |
Refer to core requirements |
|||
|
Residual disinfection claims
Testing for bacteria and viruses should be conducted at LCL for 2 separately compounded batches. If your biocide has virucidal claims, residual disinfection data is also required against the hardest-to-kill virus indicated on the label.
To make general residual bactericidal claims, you must show your biocide is effective against both:
- Staphylococcus aureus (ATCC 6538) and
- Pseudomonas aeruginosa (ATCC 15442)
For residual self-disinfecting claims and efficacy claims of dried chemical residues on hard, non-food contact surfaces, consult:
That guidance supports residual bactericidal and virucidal claims on hard, non-food contact surfaces for biocides with 24-hour residual claims.
Note: This guidance does not address residual disinfection claims against mycobacterium, fungi, yeasts or bacterial spores. It's also limited to biocides for use on hard, non-porous, non-food contact surfaces and does not address biocides for use on textile (porous) surfaces. Contact us to discuss testing requirements for other types of residual claims.
Claim | Physical form, method of application | Recommended test methods | Test organisms | Number of batches per organism, replication or carrier surfaces per batch | Inoculum or carrier count | Performance criteria for efficacy |
---|---|---|---|---|---|---|
Core bacteria test requirements for residual bacteria disinfection | ||||||
Up to 24 hr for bacteriaFootnote 1 |
Liquids Water-soluble powders Combination liquid/spray Spray Single-use towelettes |
US EPA's Protocol for Residual Self-Sanitizing Activity of Dried Chemical Residuals on Hard, Non-Porous Surface (Protocol 01-1A)Footnote 2 |
Staphylococcus aureus (ATCC 6538) and Pseudomonas aeruginosa (ATCC 15442) |
2 LCL batches, 4 carriers per batch (plus 4 controls, 2 neutralization controls) |
At least 1.0 x 105 bacteria should have survived on inoculated control squares |
99.999% mean reduction (minimum 5 log10) is required for each bacterium following 24-hr wear and re-inoculation procedure and within a 10-min contact time after sanitization test |
Bridging additional bacteria for residual disinfection | ||||||
Up to 24 hr – claim for bridging additional bacteria |
No additional data required if performance criteria against S. aureus (ATCC 6538) and P. aeruginosa have been met |
|||||
Confirmatory efficacy data test requirements for residual bacteria disinfection | ||||||
Up to 24 hr for bacteria |
All test requirements are the same as for core bacteria residual disinfection |
|||||
|
Claim | Physical form, method of application | Recommended test methods | Test organisms | Number of batches per organism, replication or carrier surfaces per batch | Inoculum or carrier count | Performance criteria for efficacy |
---|---|---|---|---|---|---|
Core test requirements for residual virus disinfection | ||||||
Up to 24 hr for virusFootnote 1 |
Liquids Water-soluble powders Combination liquid/spray Spray Single-use towelettes |
US EPA's Protocol for Residual Self-Sanitizing Activity of Dried Chemical Residuals on Hard, Non-Porous Surface (Protocol 01-1A) modified for viral testing using ASTM E1053Footnote 2 |
Most difficult-to-kill virus indicated on the label (such as small non-enveloped virus) |
2 LCL batches, 4 carriers per batch |
At least 1.0 x 104.8 virus should have survived on the inoculated control squares |
99.9% mean reduction (minimum 3 log10) for each bacterium following 24-hr wear and re-inoculation procedure and within a 10-min contact time after sanitization test Biocide should also meet non-residual viral disinfection efficacy requirements for all claimed viruses for residual hard-surface disinfection |
Bridging additional viruses for residual disinfection | ||||||
Up to 24 hr – claims for bridging additional viruses |
Liquids Water-soluble powders Combination liquid/spray Spray Single-use towelettes |
No additional data required if performance criteria for residual hard-surface disinfection against S. aureus (ATCC 6538), P. aeruginosa and hardest-to-kill virus are met |
||||
Confirmatory efficacy data requirements for residual virus disinfection | ||||||
Up to 24 hr for virus |
All test requirements are the same as for core virus residual disinfection |
|||||
|
Claim | Physical form, method of application | Recommended test methods | Test organisms | Number of batches per organism, replication or carrier surfaces per batch | Inoculum or carrier count | Performance criteria for efficacy |
---|---|---|---|---|---|---|
Core test requirements for bacteria residual sanitization | ||||||
Up to 24 hrFootnote 1 |
Liquids Water-soluble powders Combination liquid and spray Spray Single-use towelettes |
US EPA's Protocol for Residual Self-Sanitizing Activity of Dried Chemical Residuals on Hard, Non-Porous Surface (Protocol 01-1A)Footnote 2 |
Staphylococcus aureus (ATCC 6538) and Klebsiella pneumoniae (ATCC 4352) or Klebsiella aerogenes (also known as Enterobacter aerogenes) (ATCC 13048) |
3 LCL batches, 4 carriers per batch (plus 4 controls, 2 neutralization controls) |
At least 1 x 104 bacteria should have survived on the inoculated control squares |
99.9% reduction (minimum 3 log10) for each bacterium following 24-hr wear and re-inoculation procedure and within 5-min contact time following sanitization test |
Efficacy requirements for bridging of additional bacteria residual sanitization | ||||||
Up to 24 hr – bridging additional bacteria |
No additional data required to bridge additional bacteria claims if the performance criteria for residual hard-surface self-sanitization against S. aureus (ATCC 6538) and K. aerogenes (ATCC 13048) or K. pneumoniae (ATCC 4352) are met |
|||||
|
Spore and sterilant
You need efficacy testing against viable spore form (not vegetative cells) for all spore claims. If you want to label your biocide as a sporicide, sporicidal biocide or sterilant, you must have efficacy data using AOAC 966.04 against both:
- Bacillus subtilis (ATCC 19659), with spores generated using method 2 of the AOAC 966.04 in nutrient agar treated with MnSO4
- Clostridium sporogenes (ATCC 3584) with spores generated using method 1 of the AOAC 966.04 in cooked meat medium treated with MnSO4 for spore generation and inoculation of porcelain penicylinders and silk suture loops
Contact us before you submit an application to find out the acceptable data requirements to support your claims.
For all sterilant and sporicide claims, use AOAC 966.04 with:
- all tested carriers being negative for growth at the proposed contact time (unless otherwise prescribed in the test method)
- a mean control count of 1 x 105 to 1 x 106 spores per carrier
- a level of acid resistance outlined in the test
- a confirmed neutralization using growth media and incubation conditions for each microbe according to method 2 (section C, subsection h)
- verification testing using 1 batch showing all tested carriers are negative for growth at the proposed contact time
If you want to make specific claims against specific bacterial spores, you must provide supporting efficacy data. You only need to include a specific claim (for example, "inactivates spores of Clostridioides difficile" or "kills spores of Clostridioides difficile) on your label if you:
- have efficacy data to support a specific claim
- do not have the efficacy data to support your biocide as a sporicide or sporicidal biocide
For surface-specific claims against additional bacterial spores (for example, Clostridioides difficile, Bacillus anthracis, Bacillus cereus, Geobacillus stearothermophilus), we require:
- evidence your biocide is a sporicide
- 2 samples of the biocide, representing 2 separately compounded batches per bacterium
- 30 inoculated carriers of 1 type (stainless steel penicylinders, porcelain penicylinders or silk suture loops, for example) per batch per additional bacterial spore
- for example: 1 carrier type per additional bacterial spore x 30 carriers per type = 60 carriers per type per batch
If there are no general sporicide or sterilant claims, you do not need to conduct verification testing when testing only against specific bacterial spores, such as:
- Bacillus cereus (ATCC 14579)
- Bacillus anthracis (ATCC 14578)
- Clostridioides difficile (ATCC 43598)
- Geobacillus stearothermophilus (ATCC 12980)
Claim | Physical form, method of application | Recommended test methods | Test organisms | Number of batches per organism, carriers per batch | Inoculum or carrier count | Performance criteria for efficacy |
---|---|---|---|---|---|---|
Core bacteria spore test requirements | ||||||
Sterilant |
Liquids Water-soluble powders |
AOAC 966.04 (method 1: silk suture loops, method 2: porcelain penicylinders) |
Bacillus subtilis (ATCC 19659) (method 1 of AOAC 966.04 for spore production) and Clostridium sporogenes (ATCC 3584) (method 1 of AOAC 966.04 for spore production) |
3 batches 2 types of carriers (suture loop and porcelain penicylinder, as prescribed in current version of test method) 60 carriers per type per batchFootnote 1 |
Unless otherwise prescribed: Mean control count of 1 x 105 to 1 x 106 |
Unless otherwise prescribed: 720/720 carriers negative for growth at proposed contact time and for verification testing: 120/120 carriers negative for growth at proposed contact time |
Sprays, mists, foams |
A liquid biocide applied as a spray using a pump or trigger should be tested as a liquid A wetness test to demonstrate the biocide will achieve the required contact time when sprayed |
|||||
Sporicide |
Liquids Water-soluble powders |
AOAC 966.04 (method 1: silk suture loops, method 2: porcelain penicylinders) |
Bacillus subtilis (ATCC 19659) (method 2 of AOAC 966.04 for spore production) and Clostridium sporogenes (ATCC 3584) (method 1 of AOAC 966.04 for spore production) |
3 batches at least 1 type of carrier for a surface- specific sporicide claim (stainless steel penicylinder, suture loop or porcelain penicylinder), as prescribed in current version of test method) 60 carriers per type per batchFootnote 2 |
Unless otherwise prescribed: Mean control count of 1 x 105 to 1 x 106 spores per carrier, for both microbes and carrier types |
Unless otherwise prescribed: 360/360 carriers negative for growth at proposed contact time and for verification testing: 60/60 carriers negative for growth at proposed contact time (for each microorganism tested using 30 carriers) |
Sprays, mists, foams |
A liquid biocide applied as a spray using a pump or trigger should be tested as a liquid A wetness test to demonstrate the biocide will achieve the required contact time when sprayed |
|||||
Additional bacteria spore test requirements | ||||||
Claim against additional bacterial spores (for example, Bacillus cereus (ATCC 14579), Bacillus anthracis (ATCC 14578), |
Liquids Water-soluble powders |
AOAC 966.04 (method 1: silk suture loops, method 2: porcelain penicylinders) or a specific test method for the test organisms (such as C. difficile) |
Any specific bacterial spore claimed on the label along with the general sporicidal claim |
2 batches 1 type of carrier (stainless steel penicylinder, suture loop or porcelain penicylinder) 30 carriers per type per batch |
Unless otherwise prescribed: Mean control count of 1 x 105 to 1 x 106 |
Unless otherwise prescribed: 60/60 carriers negative for growth per carrier type at proposed contact time |
Sprays, mists, foams |
Liquid biocide applied as a spray using a pump or trigger should be tested as a liquid |
|||||
|
Claims supported by only Clostridioides difficile
For Clostridioides difficile (ATCC 43598)claims without a sporicide claim:
- a carrier control count of 1.0 x 106 to 1.0 x 107 spores per carrier
- a mean 6 log10 reduction based on recoverable spores within proposed contact time for all carriers
- 10 inoculated hard non-porous carriers per batch
- 3 samples of the biocide representing 3 separately compounded batches:
- AOAC 2008.05 using glass slides
- ASTM E2197 using stainless steel disks
- US EPA's 2018 test methodology against Clostridiodes difficile using:
- 430 stainless steel disks
- 3 independent tests (for example, 1 batch tested per day)
- 5% organic soil or comparable alternatives 430 stainless steel carriers or 304 stainless steel carriers if testing biocides with oxidative chemistries (for example, containing peracetic acid and peroxides)
Non-food contact and food contact sanitizers on hard surfaces
Sanitizers significantly reduce the number of microbes on a non-living and non-liquid surface due to the antimicrobial action of the active ingredients. They do not destroy or eliminate all microorganisms.
Non-food contact hard non-porous surface sanitizer
You should use vegetative bacteria for your tests to demonstrate your biocide is a non-food contact surface sanitizer. Once the biocide is demonstrated to be a non-food contact surface sanitizer, you can make additional specific bacteria non-food contact surface sanitization claims on your biocide's label (for example, Escherichia coli).
To qualify to add the claim "non-food contact surface sanitizer" to the label, you must provide efficacy data against the following core bacteria:
- Staphylococcus aureus (ATCC 6538) and Klebsiella pneumoniae (ATCC 4352) or
- Staphylococcus aureus (ATCC 6538) and Klebsiella aerogenes (ATCC 13048)
Claim | Physical form, method of application | Recommended test methods | Test organisms | Number of batches per organism, carriers per batch | Inoculum or carrier count | Performance criteria for efficacy |
---|---|---|---|---|---|---|
Core test requirements for bacteria non-food contact sanitization | ||||||
Non-food contact surface sanitizer |
Liquids Water-soluble powders |
ASTM E1153 |
Staphylococcus aureus (ATCC 6538) and Klebsiella pneumoniae (ATCC 4352) or Klebsiella aerogenes (previously known as Enterobacter aerogenes) (ATCC 13048) |
3 LCL batches (separately compounded batches per bacterium) 5 carriers per batch per bacterium |
Average of at least 7.5 x 105 As prescribed in current test method and at proposed contact time |
Unless otherwise prescribed: Less than or equal to 99.9% mean reduction (minimum 3 log10) for each bacterium within 5-min contact |
Spray Single-use towelettes |
Modified ASTM E1153 |
|||||
Test requirements for additional bacteria non-food contact sanitization | ||||||
Claim against additional bacteria |
Liquids Water-soluble powders |
ASTM E1153 |
Any specific bacteria claimed on label in addition to non-food contact surface sanitizer claim |
2 NCL batches (separately compounded batches per bacterium) 5 carriers per batch per bacterium |
Average of at least 2.5 x 104 As prescribed in current test method and at proposed contact time |
Unless otherwise prescribed: Less than or equal to 99.9% mean reduction (minimum 3 log10) for each bacterium within 5-min contact |
Spray Single-use towelettes |
Modified ASTM E1153 |
|||||
Confirmatory efficacy data requirements for bacteria non-food contact sanitization | ||||||
Non-food contact surface sanitizer |
Same requirements as for core bacteria |
2 LCL batches 5 carriers per batch |
Same requirements as for core bacteria |
Food contact surface sanitizer
To claim your biocide as a food contact surface sanitizer, you must provide efficacy data that relates to the chemical nature of your biocide (refer to Table 13). Once the biocide is demonstrated to be a food contact surface sanitizer, you may make additional specific bacteria food contact surface sanitization claims on your biocide label.
To qualify to add the claim “food contact surface sanitizer” to the label, you must provide efficacy data against the following core bacteria:
- For non-halide biocides: Staphylococcus aureus (ATCC 6538) and Echerichia coli (ATCC 11229)
- For halide biocides: Staphylococcus aureus (ATCC 6538) or Salmonella enterica (ATCC 6539)
- For towelette biocides: Staphylococcus aureus (ATCC 6538) and Echerichia coli (ATCC 11229)
Non-halide | Halide |
---|---|
|
|
Claim | Physical form, method of application | Recommended test methods | Test organisms | Number of batches per organism, carriers per batch | Inoculum or carrier count | Performance criteria for efficacy |
---|---|---|---|---|---|---|
Core test requirements for bacteria food contact sanitization | ||||||
Food contact surface sanitizer |
For non-halide biocides: Liquids Water-soluble powders Spray |
AOAC 960.09 |
Escherichia coli (ATCC 11229) and Staphylococcus aureus (ATCC 6538) |
3 LCL batches (3 separate compounded batches per bacterium) |
The numbers control must fall between 1 x 107 and 1 x 108 (7.0 to 8.0 log) |
Unless otherwise prescribed: A 5 log10 reduction of each bacterium within 30 s |
For halide biocides: Liquids Water-soluble powders Spray |
AOAC 955.16 |
Salmonella enterica (ATCC 6539) or Staphylococcus aureus (ATCC 6538) |
As prescribed in current test method |
Unless otherwise prescribed: Test results should demonstrate biocide concentrations equivalent in activity to 50, 100 or 200 ppm of available chlorine as labelled (reference standard is sodium hypochlorite) |
||
Single-use towelettesFootnote 1 |
US EPA's Draft Interim Guidance for Non-Residual Sanitization of Hard Inanimate Food Contact Surfaces Using Pre- Saturated Towelettes |
Escherichia coli (ATCC 11229) and Staphylococcus aureus (ATCC 6538) |
As prescribed in current test method |
Unless otherwise prescribed: minimum 99.999% (5 log10) reduction of each bacterium within 30 s |
||
Test requirements for food contact sanitization of additional bacteria | ||||||
Claim against additional bacteria |
For non-halide biocides: Liquids Water-soluble powders Spray |
AOAC 960.09 |
Any specific bacteria claimed on the label in addition to food contact surface sanitizer claim |
2 NCL batches (2 separately compounded batches per bacterium) Number of carriers and types of surfaces prescribed in current test method |
Numbers control must fall between 1 x 107 and 1 x 108 (7.0 to 8.0 log) |
A 5 log10 reduction of each bacterium within 30 s or less |
For halide biocides: Liquids Water-soluble powders Spray |
AOAC 955.16 |
As prescribed in current test method |
Test results should demonstrate biocide concentrations equivalent in activity to 50, 100 or 200 ppm of available chlorine as labelled (reference |
|||
Single-use towelettes |
US EPA's Draft Interim Guidance for Non-Residual Sanitization of Hard Inanimate Food Contact Surfaces Using Pre-Saturated Towelettes |
As prescribed in current test method |
Minimum 99.999% (5 log10) reduction of each bacterium within 30 s or less |
|||
Confirmatory data requirements for food contact sanitization | ||||||
Food contact surface sanitizer |
Same as core bacteria sanitization requirements |
2 LCL batches |
Same as core bacteria sanitization requirements |
|||
Abbreviation:
Footnotes
|
Residual disinfection and sanitization
Residual sanitization claims
For residual self-sanitizing claims (under 24 hours), you should test your biocide to confirm it continues to sanitize surfaces despite surface re-inoculation and abrasion. Depending on the sanitization claim, we recommend that you refer to US EPA's:
- 810.2300 and 810.2400 product performance test guidelines for general efficacy and labelling considerations for products with residual self-sanitizer efficacy or
- Protocol 01-1A for supporting residual self-sanitizing efficacy claims of dried chemical residues on hard, non-food contact surfaces
Use on alternative porous surfaces
If your biocide is for use on other types of porous surfaces, such as wood, concrete or rubber, you should:
- indicate the porous material (as a carrier) on the test protocol for the existing standard method
- develop control data (for example, dried carrier microbial count neutralization confirmation, sterility controls)
Refer to the US EPA's 810 product performance test guidelines for general efficacy and labelling considerations for products with sanitization or disinfection claims on alternative surfaces.
Pre-soak laundry sanitizers
If you used an appropriate immersion test method (for example, ASTM E1153), you may use efficacy data from a hard, non-porous 1-step sanitizer to support laundry pre-soak sanitizer claims.
The test method should be modified to include a:
- minimum of 5% organic soil
- test carrier using unglazed ceramic tile
These data may be extrapolated for the sanitization of soiled fabrics by total immersion in the use solution before routine laundry operations. Therefore, testing against the same bacteria specified in the section on the requirements for non-food contact hard non-porous surface sanitizer claims is required.
Batch replication, microbial counts and performance standards
We require the same as what is required for non-food contact hard non-porous surface sanitizer claims. The test carriers used should be unglazed ceramic tiles.
We require:
- a minimum mean of 7.5 x 105 colony-forming units (CFU) per carrier (minimum 5.88 log10 density)
- a target range of 7.5 x 105 (5.88 log) to 2.0 x 106 (6.30 log) to improve standardization and reproducibility
- results demonstrating a minimum reduction of 99.9% (3 log10 minimum) for each bacterium for the same control count
- should be demonstrated against each test microorganism within the contact time claimed on the label
For claims against additional bacteria, you should use ASTM E1153 testing with :
- an average of at least 2.5 x 104 bacteria surviving the inoculated control squares
- a less than or equal to 99.9% mean reduction (3 log10 minimum) for each bacterium within a 5-minute contact time
Page details
- Date modified: